Unmasking Cancer: How Anti-PD-L1 Awakens the Immune Attack

Noorhamizah Binti Suhaimi

MXenes in Drug Delivery

Mina Masoudi, PhD

Targeting the Breach in the Fortress Wall of Mesothelioma

Fazel Gorjipour, PhD

CRISPR-Cas9 Gene Editing: Designing a Glyco-Optimized Pichia Pastoris for Cancer Immunotherapy

Noorhamizah Binti Suhaimi

Dissecting Lung Cancer Patients Tumor Immune Microenvironment

Saif Ullah (Afridi), PhD

Developing Next-Generation Nanoscale Metal–Organic Frameworks

Ankush D. Sontakke, PhD

Focuses on retinoblastoma

Senthilkumar Palanisamy, PhD

Overcoming Barriers: Drug-Loaded Nanobubbles for Brain Cancer Therapy

Shoeb Anwar Ansari, PhD

Lung mucosa: pro-tumor vs. anti-tumor playground

Müge Özkan, PhD

Nanomedicine-based targeting therapy could overcome the challenges of multiple myeloma: Novel insight from NanoBio4Can Program

Nemany Abdelhamid Nemany Hanafy, PhD

Combining Two Treatments in One Smart Nanosystem

Melike Belenli Gümüş, PhD

Tiny Bubbles, Big Hope: How Smart Nanomedicine Could Transform Liver Cancer Treatment

Kashif Maroof, PhD